Wayzim(SH:688211)2023-04-27 16:00Financial Performance - The company's operating revenue for Q1 2023 reached ¥291,155,185.76, representing a year-on-year increase of 290.36%[5] - Net profit attributable to shareholders of the listed company was ¥31,665,379.43, with a significant increase attributed to project acceptance and revenue growth[10] - Basic and diluted earnings per share were both ¥0.24, reflecting the increase in net profit during the reporting period[10] - Net profit for Q1 2023 reached CNY 31,665,379.43, while Q1 2022 recorded a net loss of CNY 10,692,103.68[22] - The net profit for Q1 2023 was ¥29,275,673.29, compared to a net loss of ¥9,066,660.49 in Q1 2022, indicating a turnaround in profitability[30] Cash Flow - The cash flow from operating activities amounted to ¥226,327,468.86, indicating an increase in customer payments received during the reporting period[10] - Cash flow from operating activities in Q1 2023 was CNY 226,327,468.86, a significant improvement from a negative cash flow of CNY 48,461,632.56 in Q1 2022[24] - The company's cash flow from operating activities for Q1 2023 was ¥189,526,243.25, a recovery from a negative cash flow of ¥54,009,731.32 in Q1 2022[30] - The company reported a significant increase in cash received from operating activities, totaling ¥909,063,697.75 in Q1 2023, compared to ¥493,463,362.71 in Q1 2022, marking an increase of about 84.5%[30] Assets and Liabilities - The total assets at the end of the reporting period were ¥5,411,995,541.93, a decrease of 2.55% compared to the end of the previous year[8] - The total assets as of March 31, 2023, amounted to ¥4,927,389,282.88, slightly down from ¥4,989,623,123.20 at the end of 2022[27] - The company's total liabilities decreased to approximately ¥1.60 billion as of March 31, 2023, down from ¥1.77 billion, a decline of 9.4%[18] - Total liabilities as of March 31, 2023, amounted to CNY 1,820,766,271.95, down from CNY 1,984,238,301.51 in the previous year[22] Research and Development - Research and development expenses totaled ¥51,273,769.04, accounting for 17.61% of operating revenue, reflecting an increase of 58.61% compared to the previous period[10] - Research and development expenses for Q1 2023 were CNY 51,273,769.04, compared to CNY 32,327,600.98 in Q1 2022, indicating a 58.7% increase[21] - The company's research and development expenses for Q1 2023 were ¥47,409,560.61, up from ¥29,334,395.17 in Q1 2022, indicating an increase of about 61.6%[29] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 13,779, indicating a stable shareholder base[12] - The top ten shareholders held a combined 70.08% of the shares, with the largest shareholder holding 20.52%[12] Inventory and Orders - The inventory value increased to approximately ¥1.60 billion as of March 31, 2023, compared to ¥1.50 billion at the end of 2022, indicating a rise of 6.5%[18] - The company reported a total of ¥22.87 billion in hand orders as of March 31, 2023, with the top five customers accounting for 21.39%, 16.11%, 9.08%, 7.62%, and 5.25% of the total[15] Cash and Cash Equivalents - As of March 31, 2023, the total cash and cash equivalents amounted to approximately ¥555.86 million, an increase from ¥461.26 million as of December 31, 2022, reflecting a growth of 20.5%[18] - Cash and cash equivalents at the end of Q1 2023 were CNY 311,462,627.63, down from CNY 881,915,154.73 at the end of Q1 2022[24] Other Financial Metrics - The company reported non-recurring gains of ¥12,556,399.65 after tax, with significant contributions from various non-operating income sources[9] - The company has a significant increase in other equity instrument investments, rising to ¥98 million from ¥20 million, a growth of 390%[18] - The company's accounts receivable decreased to approximately ¥468.91 million from ¥858.20 million, a reduction of 45.4%[18]